摘要
目的探讨腹腔镜袖状胃切除术(LSG)治疗肥胖症患者的减重效果及其对合并疾病的改善情况,评估手术安全性。方法回顾性分析2016年1月至2018年12月在贵州省人民医院接受LSG手术的58例肥胖症患者临床资料,观察患者术后减重效果、合并疾病改善情况及术后并发症发生情况。结果患者均顺利完成LSG手术,术后第3、6、12个月平均多余体质量减轻百分比(%EWL)分别为(65.4±12.3)%、(71.2%±15.2)%、(74.7±16.7)%;合并疾病脂肪肝、肝功能异常、血脂异常、呼吸睡眠暂停综合征、高血压、2型糖尿病和高尿酸血症的术后1年疾病缓解率分别为74.3%、78.3%、70.0%、56.3%、85.7%、100.0%、80.0%,术后均得到显著改善(P<0.05)。术后近期并发症发生率为3.4%(2/58),远期并发症主要为胃食管反流症、胆囊结石和急性胰腺炎。结论LSG可有效减轻肥胖患者的体质量,改善肥胖相关合并疾病,而且手术并发症发生率较低,相对安全,值得推广。
Objective To analyze the effectiveness and safety of laparoscopic sleeve gastrectomy(LSG)in treating obesity and its co-morbidities.Methods The clinical data of fifty-eight patients with obesity who underwent LSG in Guizhou Provincial People’s Hospital from January 2016 to December 2018 were retrospectively analyzed.The effect of weight loss,the improvement of combined diseases and postoperative complications were observed.Results All operations were successfully completed in LSG.The mean%EWL at 3,6 and 12 months after surgery were(65.4±12.3)%,(71.2%±15.2)%and(74.7±16.7)%respectively.The combined diseases were fatty liver,liver dysfunction,dyslipidemia,obstructive sleep apnea,hypertension,type 2 diabetes mellitus and hyperuricemia,which were significantly improved by 74.3%,78.3%,70.0%,56.3%,85.7%,100.0%and 80.0%one year after surgery.Early complications occurred in 3.4%(2/58)of patients,and the common late complications were gastroesophageal reflux disease,cholecystolithiasis and acute pancreatitis.Conclusion LSG is effective and safe in treating obesity and its co-morbidities.
作者
王少勇
李沁宇
张忠民
王光辉
Wang Shaoyong;Li Qinyu;Zhang Zhongmin;Wang Guanghui(Department of General Surgery,Guizhou Provincial People’s Hospital,Guiyang 550002,China)
出处
《中华普通外科学文献（电子版）》
2020年第4期257-260,共4页
Chinese Archives of General Surgery(Electronic Edition)
基金
国家自然科学基金青年项目(81802479)
贵州省科学技术基金项目(黔科合字〔2012〕2229号)
贵州省卫生健康委科学技术基金项目(gzwjkj2019-1-124)。
